Report : North America Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Enzyme (Cryopreserved Amniotic Membrane, and Dehydrated Amniotic Membrane); Application (Surgical Wounds, Ophthalmology, and Others); End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research Institute and Academic Institutes), Country

Cryopreserved Amniotic Membrane Segment Held Largest Share of North America Amniotic Membrane Market in 2019


According to a new market research study of ‘North America Amniotic Membrane Market to 2027 – Regional Analysis and Forecast by Product, Technology and Application,the Asia Pacific Liposome Drug Delivery market is expected to reach US$ 1175.2million in 2027 from US$ 667.4 in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020-2027. . The report provides trends prevailing in the North America amniotic membrane market and the factors driving market along with those that act as hindrances.


Based on the product, the North America the amniotic membrane market, by enzyme, is segmented into cryopreserved amniotic membrane, and dehydrated amniotic membrane. The cryopreserved amniotic membrane segment held the largest share of the market in 2019, whereas the dehydrated amniotic membrane segment is anticipated to register the highest CAGR in the market during the forecast period.

The human amniotic membrane is widely used as a graft or a dressing in surgical procedures. Hence, they are cryopreserved in glycerol at −80 °C for several months. Additionally, it has been reported that tissue can been stored at −80 °C for about 2 years. Cryopreservation at −80 °C and in an appropriate cryoprotectant media enables conservation for longer period of time. Furthermore, the study ‘Biological Differences between Cryopreserved and Dehydrated Amniotic Membrane Tissue Grafts’ reported that cryopreservation process better conserves the structural integrity and biochemistry of AM tissue grafts as compared to dehydrated grafts. However, the dehydrated amniotic membrane segment is predicted to grow at a higher CAGR. This is because dehydrated amniotic membrane is used for broad range of applications however, it is widely used for treatment of a no healing defect on the ocular surface such as a neurotrophic corneal ulcer. Also, market players are providing dehydrated amniotic membrane are easy to use and ideal to handle. For instance, Human Regenerative Technologies, LLC offer thin amniotic membrane and thick amniotic membrane that is dehydrated and is created for maximum ease and versatility. It adheres naturally to the surface and does not require suturing. It also has a shelf life of 5 years


The growth of the market is attributed to some key driving factors such as high implementation of amniotic membranes in medical science and new developments and increased investments of amniotic membranes. However, limitations encountered while using amniotic membranes in emerging nations are expected to obstruct the growth of the market to a certain extent during the forecast years.


Skye Biologics Inc., Integra Life Sciences Corporation, and Applied Biologics LLC are among the leading companies operating in the North America mammography systems market. 


North America Amniotic Membrane Market

North America Amniotic Membrane Market

The report segments North America Amniotic Membrane Market as Follows:

By Enzyme

  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane

By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics
  • Research Institute and Academic Institutes

By Country

  • North America
    • US
    • Canada
    • Mexico
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id:     

Download Free PDF Brochure